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Abstract
Background: Bacteria of the genus Sneathia are emerging as potential pathogens of the female reproductive tract.
Species of Sneathia, which were formerly grouped with Leptotrichia, can be part of the normal microbiota of the
genitourinary tracts of men and women, but they are also associated with a variety of clinical conditions including
bacterial vaginosis, preeclampsia, preterm labor, spontaneous abortion, post-partum bacteremia and other invasive
infections. Sneathia species also exhibit a significant correlation with sexually transmitted diseases and cervical
cancer. Because Sneathia species are fastidious and rarely cultured successfully in vitro; and the genomes of
members of the genus had until now not been characterized, very little is known about the physiology or the
virulence of these organisms.
Results: Here, we describe a novel species, Sneathia amnii sp. nov, which closely resembles bacteria previously
designated “Leptotrichia amnionii“. As part of the Vaginal Human Microbiome Project at VCU, a vaginal isolate of
S. amnii sp. nov. was identified, successfully cultured and bacteriologically cloned. The biochemical characteristics
and virulence properties of the organism were examined in vitro, and the genome of the organism was
sequenced, annotated and analyzed. The analysis revealed a reduced circular genome of ~1.34 Mbp, containing
~1,282 protein-coding genes. Metabolic reconstruction of the bacterium reflected its biochemical phenotype, and
several genes potentially associated with pathogenicity were identified.
Conclusions: Bacteria with complex growth requirements frequently remain poorly characterized and, as a
consequence, their roles in health and disease are unclear. Elucidation of the physiology and identification of
genes putatively involved in the metabolism and virulence of S. amnii may lead to a better understanding of the
role of this potential pathogen in bacterial vaginosis, preterm birth, and other issues associated with vaginal and
reproductive health.
Background
A recent study, based on phylogenetic and phenotypic
analyses, showed that the organism previously named
“Leptotrichia sanguinegens” should be reassigned to a
separate genus. Thus, the genus Sneathia was described,
and the species was formally named Sneathia sanguine-
gens [1]. Species of this genus are long, gram-negative,
non-motile rods that sometimes exhibit bulbous protru-
sions [2]. A novel bacterium that is closely related to
S. sanguinegens was isolated from amniotic fluid and
published as “Leptotrichia amnionii” [3]. The species was
not validly named and no type strain was designated.
Subsequently, 16S rDNA phylogenetic analysis showed
that “L. amnionii” is better assigned to the genus
Sneathia [4]. Herein, we describe a vaginal isolate that
phenotypically and phylogenetically resembles this
bacterium. Our genomic and phenotypic data clearly sup-
port the reclassification of this species to the genus
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Sneathia, and we propose the designation Sneathia amnii
sp. nov. The type strain of S. amnii is Sn35.
Sneathia species have been associated with serious
obstetric complications including spontaneous abortions
and preterm labor [3,5,6]. While the uterine cavity and
amniotic fluid are usually sterile, bacterial infection can
occur and is frequently associated with preterm labor
and preterm premature rupture of fetal membranes [7].
Sneathia is one of the most common genera detected in
amniotic fluid, and its presence can lead to inflammation,
histological chorioamnionitis, and/or amnionitis [8]. Two
recent studies investigated the rates of bacterial invasion
of the amniotic cavity. Amniotic fluid samples were ana-
lyzed for the presence of bacteria, and of samples from
women with preeclampsia that were positive for bacteria,
50% contained Sneathia while in samples from women
presenting with preterm labor that were positive for bac-
teria, 25% contained Sneathia [9,10]. These findings sug-
gest that Sneathia has the pathogenic capacity to invade
the uterine cavity and the amniotic sac and thereby cause
pregnancy complications. Sneathia has also been impli-
cated in both infant and maternal post-partum bactere-
mia [11-13]. More recently, a case of septic arthritis in a
healthy, non-pregnant woman was reported, demonstrat-
ing that this opportunistic pathogen has the potential to
cause infections outside of the reproductive tract as well
[11-13].
Sneathia has also been associated with bacterial vagino-
sis (BV), the most common vaginal disorder in women of
reproductive age worldwide [14]. BV is thought to be a
clinically significant disorder because it is associated with
increased risk for preterm labor and increased rates of
transmission of HIV and other sexually transmitted infec-
tions (STIs). BV is characterized by a decline in the num-
ber of healthy vaginal lactobacilli (long rods), and an
increase in number of short rod-shaped and coccoid anae-
robic bacteria. The overall bacterial load and species diver-
sity are both drastically elevated in BV. The etiology of the
disorder is poorly defined, complicating therapy, and BV
tends to be recurrent [15]. Recent culture-independent
techniques that comprehensively identify bacterial taxa
associated with BV have been employed in an effort to
better understand its etiology. Although these studies have
revealed an association between BV and the presence of
Sneathia sp., the role of these bacteria in the etiology and
pathology of the disease remains undefined [16-18].
A recent study of the microbiome of the male urogen-
ital tract found that men can also be colonized with
Sneathia, and that there is a significant correlation
between colonization with Sneathia and other sexually
transmitted pathogens, suggesting that these bacteria can
be sexually transmitted [19]. Another study investigated
the rate of Sneathia colonization in female subjects with
human papillomavirus (HPV), and while there was not a
positive correlation between HPV and Sneathia, there
was a significant correlation between colonization with
S. amnii (”L. amnionii”) and cervical cancer in HPV-
positive subjects [20].
In summary, Sneathia appears to be a significant, emer-
ging opportunistic pathogen that may play a significant
role in vaginal and reproductive health. However, due to
its fastidious nature, very little is known about the genus.
Our analysis of mid-vaginal microbiome profiles from
over 700 women who were recruited as part of the Vaginal
Human Microbiome Project [21], revealed that Sneathia
species, and especially S. amnii sp. nov., commonly inhabit
the human vagina. In an effort to better define this micro-
organism, we cultured a vaginal isolate of Sneathia, ana-
lyzed its genetic virulence potential, and characterized its
virulence properties in vitro. Herein, we describe S. amnii
sp. nov. as a novel species that closely resembles isolates
formerly designated as “L. amnionii,” and designate the
type strain as S. amnii Sn35. Furthermore, we sequenced
and analyzed the genome of this strain, which represents
the first genome for the Sneathia genus.
Results and discussion
Sneathia species are a common component of the
vaginal microbiota
We collected mid-vaginal samples from 736 women visit-
ing urban outpatient clinics in Virginia [21] for a variety of
reasons (e.g., annual examination, vaginal discharge, STI
screening, pregnancy, etc.). To identify the diversity of spe-
cies present in these samples, we targeted the V1-V3
region of the 16S ribosomal-RNA-encoding gene. We
applied a deep-sequencing approach that generated an
average of ~30,000 reads per sample (mean = 30,165,
median = 28,223), and therefore were able to detect taxa
present in low abundance. Sneathia species were found in
43.3% (319 of 736) of these samples using an abundance
threshold of 0.1% of total reads (Figure 1a). Using a more
stringent abundance threshold of 1% of total reads (i.e.,
approximately 300 reads for an average sample), we still
detected Sneathia in 30.0% of samples. Notably, in three
mid-vaginal samples, more than half of the total reads
classified to Sneathia. Thus, organisms in the genus
Sneathia are common members of the vaginal micro-
biome, and they are occasionally identified as the predomi-
nant taxa.
S. amnii in mid-vaginal microbiome profiles
The reference sequences of the V1-V3 regions of the 16S
rRNA genes of S. sanguinegens and S. amnii sp. nov. are
only 91% identical, permitting clear separation of the 16S
rDNA metagenomic reads from these two species.
Although we detected both S. sanguinegens and S. amnii
in the mid-vaginal samples, the majority of Sneathia
reads (76.3%) classified to S. amnii (Figure 1b). Moreover,
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Figure 1 Prevalence of Sneathia species in mid-vaginal samples. (A) Relative abundance of Sneathia species in mid-vaginal samples.
Sneathia was identified by 16S rDNA analysis in 319 of 736 mid-vaginal samples collected from volunteers recruited from outpatient clinics
using a 0.1% abundance threshold; i.e., Sneathia was considered present if at least 0.1% of total 16S rRNA reads classified to Sneathia. (B)
Abundance of different species of Sneathia (S. sanguinegens, S. amnii, or non-speciated Sneathia) in mid-vaginal samples. The majority of Sneathia
reads (76.3%) identified in the mid-vaginal microbiome profiles classify to Sneathia amnii.
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both S. amnii and S. sanguinegens often co-occur in mid-
vaginal samples. Using a 0.1% abundance threshold for
presence, both S. amnii and S. sanguinegens were
detected in 70.1% of mid-vaginal samples containing at
least one of the two Sneathia species. However, approxi-
mately 6% of all reads classified as Sneathia do not
clearly classify to one of the two known Sneathia species.
Our preliminary results indicate that there is likely a
third, less-abundant vaginal Sneathia that has yet to be
described. Reads classified to the novel putative Sneathia
taxon were detected in 1.4% of samples using a 0.1%
abundance threshold, representing 1.3% of all reads clas-
sifying to Sneathia at the genus level. The V1-V3 rDNA
sequences from these bacteria are ~91% and ~93% iden-
tical to corresponding rDNA sequences from S. amnii
and S. sanguinegens, respectively, and these differences do
not appear to be due to sequence errors or chimeras (data
not shown). Thus, our results suggest that at least three
related Sneathia types are found in vaginal samples.
Herein, we focus on characterizing the S. amnii isolate,
which we have successfully cultured and cloned, although
we are continuing to attempt to culture and clone vaginal
isolates of S. sanguinegens and the third, as yet unnamed,
putative Sneathia.
Phylogenetic analysis of the 16S rDNA of S. amnii
To better define the role of S. amnii sp. nov. in vaginal
health and disease, we isolated a clone from a mid-vaginal
sample taken from an African American woman in her
early 20’s presenting with symptoms of preterm labor at
26 weeks of gestation. The 16S rRNA gene of this isolate
was sequenced in its entirety and aligned with the 16S
rDNAs from other members of Fusobacteriaceae family
(Additional file 1) to assess their phylogenetic relationships
(Figure 2). This alignment showed that the 16S rDNA of
our isolate is 99.8% identical to the 16S rDNA of the iso-
late first described as “L. amnionii” (accession number
AY078425.1). This result, along with phenotypic charac-
teristics, suggests that the Sneathia isolate described
herein is very similar to the bacterium previously
described by Shukla et al. (2002) [3]. Furthermore, the 16S
rDNA of our Sneathia isolate exhibited 94.7% overall
sequence identity to S. sanguinegens (accession numbers
L37789.1 and NR_025487.1), but only 84.4% overall
sequence similarity to Leptotrichia buccalis (accession
numbers L37788.1), the type species of the genus Leptotri-
chia. Phylogenetic analysis of the 16S rDNA gene, are con-
sistent with the classification of this bacterium to the
genus Sneathia, as previously proposed by Eribe et al. [4]
for the bacterium termed L. amnionii. Therefore, we
propose S. amnii sp. nov. as the name for the species.
Our analyses also confirm, as previously shown [1], the
close relationship (~88% across the rDNA, and similar
relationships among other genes) between Sneathia and
Streptobacillus moniliformis, the causative agent of Rat
bite fever [22].
The genome of S. amnii sp. nov
General features of the S. amnii genome are shown and
compared to the genomes of the related bacteria
S. moniliformis, L. buccalis, and Sebaldella termiditis in
Table 1. The genome was sequenced to ~245 fold cov-
erage using Roche 454 FLX Titanium technology, and
this sequence assembled into one scaffold of 1,339,284
bases (Figure 3). This initial assembly was interrupted
by 27 sequence gaps ranging from ~225 to 4200 nucleo-
tides. Gaps within the scaffold were filled by PCR ampli-
flication and capillary sequencing of the amplicons.
Although mate pair sequencing permitted the assembly
of the genome into a single circular scaffold, the final
(~11) sequence gaps represent a very small fraction of
the genome (a few hundred bases) and therefore are
unlikely to impact our analyses.
The genome of Sneathia amnii is approximately 1.34
Mbp and has a GC content of ~28%. Thus, this organism
exhibits the smallest of the Fusobacteriaceae family gen-
omes sequenced to date. A representative from each of the
most closely related genera; i.e., S. moniliformis (1.67
Mbp), L. buccalis (2.47 Mbp), and S. termiditis (4.49
Mbp), was selected for genomic comparisons. The
S. amnii genome exhibits 1,282 putative protein-coding
genes, with an average gene length of 969 bp (323 amino
acids), constituting 92% of the genome. Thus, the coding
density of the genome is quite high. S. amnii intergenic
regions have an average length of 80 bp, very similar to
the 77 bp average intergenic size of S. moniliformis. The
genomes of L. buccalis and S. termiditis have slightly larger
intergenic regions, averaging 129 and 128 bp, respectively
(Table 1). However, several studies have found no signifi-
cant correlation between bacterial genome size and aver-
age intergenic region lengths [23]. We found that the
differences in the gene composition account for the differ-
ence in the genome sizes of these related organisms.
Although the genome of S. amnii is relatively small, its
gene density (968 genes/Mbp) is higher than the average
gene density of related members of the Fusobacteriaceae
family, including S. moniliformis, L. buccalis and S. termi-
ditis. This high gene density of S. amnii seems to be attri-
butable to numerous overlapping genes. Our evidence also
suggests that the S. amnii genome contains at least 110
overlapping genes. The compact genome of this organism
supports a hypothesis that it is subject to selective pressures
that attribute high cost to genome size and replication.
Of the 1,282 predicted genes of S. amnii, 852 (~66%)
clustered into COG orthologous groups [24] and could
be associated with a putative function. A comparison of
COG functional groups for the selected Fusobacteriaceae
genomes revealed a correlation of gene content with
Harwich et al. BMC Genomics 2012, 13(Suppl 8):S4
http://www.biomedcentral.com/1471-2164/13/S8/S4
Page 4 of 15
genome size (Figure 4). As observed previously [25],
among the four taxa that we examined, gene contents for
COG classes J, L, D and F are generally inversely corre-
lated to genome size, whereas classes K, N, T, and Q are
generally positively correlated. COG groups J, L, D and F
generally deal with DNA replication, cell cycle regulation
and protein translation, whereas COG groups K, N, T
and Q are associated with transcription, signal transduc-
tion, cell motility and the biochemistry of secondary
metabolites (Figure 4, and Additional file 2). There is a
Table 1 General features of S. amnii genome and related organisms.
S. amnii S. moniliformis L. buccalis S. termiditis
Approximate Genome Size (bp) 1,339,284 1,673,280 2,465,610 4,486,650
Total DNA Coding region (b) 1,207,722 1,556,870 2,139,206 3,918,335
Average intergenic region (b) 80 77 129 128
Average gene density (genes/Mbp) 968 903 935 938
G+C content (%) 28.30 26.28 29.65 33.38
tRNA genes 34 39 46 40
Predicted ORFS1 1,282 1,511 2,306 4,210
Average ORF size in bp (aa)2 942 (314) 1014 (338) 924 (308) 927 (309)
Genes assigned to COGs3 1,042 1,111 1,731 2,229
Genes associated with a putative function4 852 907 1306 2164
Genes with signal peptides 137 262 432 801
Genes with transmenbrane helices 257 343 530 901
1Open reading frames predicted as described in the Materials and Methods;
2Average ORFs sizes shown herein were calculated using protein-coding sequences available at GeneBank: S. moniliformis (1434 protein sequences), L. buccalis
(2220 protein sequences) and S. termiditis (4083 protein sequences);
3Clusters of orthologous groups as described in the Materials and Methods;
4Genes assigned to general functional prediction only (Category R) and function unknown (Category S) were not included.
Figure 2 Maximum likelihood phylogenetic tree of S. amnii and related organisms within the family Fusobacteriaceae. The tree was
inferred from 1,271 aligned characters of the 16S rRNA gene sequence (Additional file 1) and rooted in accordance with the current taxonomy.
Numbers at nodes correspond to the support values from 1,000 bootstrap replicates.
Harwich et al. BMC Genomics 2012, 13(Suppl 8):S4
http://www.biomedcentral.com/1471-2164/13/S8/S4
Page 5 of 15
rationale for this in that as the genome size becomes
compressed, functions of cell motility and signaling,
which are dispensable or can be ‘outsourced’ to the host,
are lost, while essential functions like DNA replication
are maintained. As the total number of genes is reduced,
the less important functions become a lower percentage
of the remaining genes, and the more important func-
tions become a higher percentage of the total. This trend
was also apparent among genes not characterized in
COG, which is probably not surprisingly since these
genes are likely to be involved in more specialized pro-
cesses and may not be essential for growth and survival.
Interestingly, whereas a positive correlation between gen-
ome size and COG class C (energy production and con-
version) has previously been reported, we did not observe
this correlation in our analysis of these four genomes
(Figure 4). Thus, the general characteristics of this gen-
ome are fairly typical of a pathogen under pressure to
Figure 3 Genomic atlas of S. amnii Sn35. Coordinates are indicated starting from the predicted origin of replication at base 1. Circles
represent the following (from the outer circle inward): 1) Coding regions are marked on the first two rings: orange color if encoded on the
positive strand and teal color if encoded on the negative strand. 2) location of the tRNA. 3) GC content using a 10-kbp sliding window, green,
positive GC skew; gray, negative GC skew. The innermost graph shows the GC skew, with sharp changes in skew occurring at the putative origin
and terminus of replication. The atlas was constructed using DNAPlotter [58].
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tailor its genetic capabilities to the bare essentials while
taking maximum advantage of a close relationship with
its mammalian host.
Central metabolism
Analysis of the metabolic potential of S. amnii provided
insight into the biochemical reactions underlying the
complex growth requirements of this fastidious organ-
ism. Our genome-wide metabolic reconstruction ana-
lyses suggested that S. amnii is able to metabolize a
limited variety of carbohydrates, including glucose, mal-
tose, glycogen and glucosamine. In contrast, Sneathia
would be unable to ferment starch, mucin and mannose.
The key enzymes; i.e. hexokinase, fructokinase, galacto-
kinase, mannokinase and rhamnulokinase, needed for
these conversions of the latter carbohydrates are missing
in the genome of S. amnii. Fermentation assays con-
firmed that, as predicted, S. amnii ferments glycogen,
maltose, and glucose, but not starch, galactose, mucin,
mannose, sucrose or fructose. In addition, lactic acid
was produced during fermentative metabolism as pre-
dicted by metabolic analyses. Since S. termiditis, L. buc-
calis and S. moniliformis, which clearly arose from a
progenitor common to S. amnii, maintain these capabil-
ities, these results support the hypothesis that S. amnii
sp. nov. has lost many of the capabilities of its progeni-
tors (Additional file 2).
Glycogen is produced by vaginal epithelial cells in
women of reproductive age, and many known vaginal
colonizers (e.g., the Lactobacillaceae) utilize this carbo-
hydrate source. Therefore, it was not surprising that S.
amnii, with its “reduced” metabolic capabilities, still
effectively utilizes glycogen but can ferment only a few
alternative carbon sources. Glycogen and glucose are
the most abundant carbohydrate sources in the vagina,
but fructose, mannose, glucosamine and starch are also
present in lower amounts [26]. Maltose is an intermedi-
ate of glycogen metabolism and it is possible that S.
amnii acquires this nutrient source from other bacteria
that share the niche.
In silico analysis of the S. amnii genome revealed
complete phosphotransferase systems (PTSs) for man-
nose, galactitol and cellobiose. Since we have empirically
shown that S. amnii cannot metabolize mannose or
galactose, the role(s) of these systems is unclear. In con-
trast, the majority of the sugar transporter PTS systems,
including those for beta-glucosides, D-glucosamine,
fructose, glucose, lactose, mannitol and sucrose, are
incomplete. For these systems, genes for an EIIA com-
ponent (phosphocarrier protein HPr) are present, but no
genes encoding putative permeases were identified.
Thus, the functions of these incomplete PTS systems
are currently unknown. Some studies suggest that,
instead of carbohydrate transport, some of the enzymes
in these systems may be involved in regulation of other
biochemical pathways [27].
Gene function
Energy metabolism
Genes encoding enzymes of the non-oxidative branch of
the pentose phosphate pathway (PPP), including the
genes for transaldolase and transketolase, were identified
Figure 4 Comparison of the distribution of predicted proteins of S. amnii and related organisms. Predicted ORFs from S. amnii, S.
moniliformis, L. buccalis and S. termiditis were classified into COG functional categories. The percent of genes belonging to each COG is
represented for each species.
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in the genome. These enzymes link the PPP with glyco-
lysis by catalyzing the conversion of dietary 5 carbon
sugars into both 6 (fructose-6-phosphate) and 3 (glycer-
aldehyde-3-phosphate) carbon sugars, which can then be
utilized by the pathways of glycolysis. It has been sug-
gested that some human pathogens turn to gluconeo-
genesis to sustain growth when faced with limited sugar
substrates [28]. However, our analyses suggest that
S. amnii cannot use this strategy, since fructose bispho-
sphatase, an essential gene for gluconeogenesis, is appar-
ently not present in its genome. Since the organism is
anaerobic (see below), although moderately aerotolerant,
it was not unexpected that enzymes for oxidative phos-
phorylation (e.g., fumarate reductase, succinate dehydro-
genase) were absent from the genome. Additionally, the
tricarboxylic acid (TCA) cycle of S. amnii appears to be
absent, since only one of its required enzymes, dihydro-
lipoamide S-succinyltransferase, was detected in the 1.34
Mbp genome of the bacterium.
Amino acid and nucleotide biosynthesis
Loss of genes required for biosynthesis of amino acids is
common among opportunistic pathogenic bacteria [29],
and we found that S. amnii also lacks the enzymes
required to synthesize most amino acids. In contrast,
however, the enzymes needed to convert L-aspartate to
fumarate, L-asparagine, and oxaloacetate appear to be
present in the genome. In addition, many of the required
enzymes that convert L-amino acids to D-amino acids
were identified. As for genes required for amino acid bio-
synthesis, the genes required for de novo synthesis of pur-
ines and pyrimidines were not identified in the genome
of S. amnii. However, several components of the salvage
pathways for purine and pyrimidine biosynthesis were
present. Thus, S. amnii apparently relies on the purine
nucleotide salvage via adenosine and hypoxanthine. Ade-
nosine is likely to be imported from host cells and con-
verted into inosine by purine nucleoside phosphorylase.
Hypoxanthine also appears to be derived from the host
cell and then converted to inosine-5’-monophosphate
(IMP) by hypoxanthine-guanine phosphoribosyltransfer-
ase. IMP serves as the precursor for both AMP and
GMP, which are further converted to triphosphates. As
part of the purine salvage process, the enzymes purine-
nucleoside phosphorylase and xanthine-guanine phos-
phoribosyltransferase are also encoded in this genome,
and they are responsible for the conversion of the
xanthosine to either xanthine or guanine to XMP or
GMP, respectively. In addition, there are two alternative
salvage pathways by which bacteria convert uridine to
UMP. One is catalyzed by uracil phosphoribosyltransfer-
ase, the other requires the sequential enzymatic reactions
of uridine phosphorylase and uridine kinase. Uridine
kinase also converts cytidine to CMP. These key compo-
nents of the pyrimidine salvage pathway are encoded in
the S. amnii genome. Thus, despite the lack of many
enzymes required for amino acid and nucleotide synth-
esis, S. amnii seems to be able to scavenge what it needs
from its hosts.
DNA repair and exchange
A number of genes predicted to encode proteins involved
in DNA modification and repair were also detected. Thus,
we identified a putative DNA restriction-modification sys-
tem. There are two genes encoding putative competence
related proteins, but a complete system for genetic compe-
tence is apparently lacking, since the complex named
RecBCD, composed of three different subunits called
RecB, RecC, and RecD, was not found. Genes encoding
apparent recombination proteins, including RecA, RecG,
RecX, RecF, RecR, RuvABC, and viral RecT, were present.
The genome contains a uvrD homolog, but, like other
pathogenic bacterial species with minimal genomes [30],
other genes involved in UV-induced DNA repair, includ-
ing uvrABC, were not found and seem to be absent.
The S. amnii genome bears a complete temperate
prophage genome in addition to several individual phage-
related genes dispersed throughout the genome. The
prophage consists of a 20,259 kbp sequence containing
both a lysogeny module, including putative integrase and
repressor genes, and a replicative module, including genes
encoding terminase, portal and tail proteins. Other phage-
related genes encoding integrases, a replisome organizer
and a capsid are distributed throughout the genome. Two
identical 1.2 kbp insertion sequences are also present in
the Sneathia genome. This insertion sequence has 99%
identity to IS605, which was previously reported in the
BV-associated Clostridiales species BVAB3, suggesting a
possible cross genus transmission.
In brief, S. amnii exhibits the capacity for general DNA
recombination and repair and while it does not appear to
have the capacity for high-level natural competence, it has
clearly acquired exogenous DNA, possibly through phage
transduction and/or other mechanisms.
Transport
Few genes encoding known secretion systems were found;
however, several genes predicted to encode homologs of
the Type II protein secretion machinery (T2SS) were
detected. Normally, components of T2SS are encoded
within an operon located at a single genomic locus,
although single genomes can contain multiple, discontigu-
ous T2SS [31]. S. amnii contains genes homologous to
both PulF/PilC and GspD proteins in a single locus. A sec-
ond locus encodes a GspE homolog, hypothesized to be
the ATPase that energizes Type II secretion, and a SecA
homolog is located at a third locus. Taken together, these
observations suggest that S. amnii has functional Sec and
Type II secretion systems, although other protein secretion
Harwich et al. BMC Genomics 2012, 13(Suppl 8):S4
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systems that were not identified by our analyses may also
be present. In addition, there are many genes apparently
related to small molecule transport, including ~40 ABC-
type transporter genes, ~13 genes involved in ion trans-
port, and ~7 multidrug/lipid/protein pumps. Apparent
homologs of the F1F0 ATPase were also detected. In brief,
S. amnii seems to be well equipped to obtain vitamins,
cofactors and other nutrients from its environment.
Growth requirements
S. sanguinegens reportedly requires blood for growth [11].
In contrast, S. amnii did not require blood for growth,
but its growth rate was enhanced by the addition of
human serum (not shown). S. amnii grew well on choco-
late agar. Colonies appeared after 48 h, and by 72 h the
colonies were flat, ~1 mm in diameter, and crystalline.
S. amnii did not grow on Brucella Sheep’s blood agar but
colonies on BHI agar containing 10% fresh human blood
were mucoid, raised, amorphous, ~2 mm in diameter,
and displayed alpha hemolytic activity. Consistent with
our predictions from the genome analysis, S. amnii was
catalase-negative and grew only under anaerobic condi-
tions. However, it was able to tolerate transient exposure
to air and was positive for superoxide dismutase activity.
Interestingly, the genome did not contain an obvious
gene encoding superoxide dismutase, and maximum
identity to superoxide dismutase proteins, as detected
using blastx, was 30%.
Morphology
Scanning electron microscopy of S. amnii (Figure 5a)
revealed variable morphology including long (10+ μm)
gram-negative rods as well as short, amorphous rods and
cocci. Similar short morphotypes have been reported for
S. moniliformis [32], and other bacteria, and are referred to
as “L forms”. The L forms of S. moniliformis are reportedly
deficient in cell walls and thought to be non-pathogenic.
S. amnii L-forms were more common in older cultures,
although actively growing cultures were predominated by
the bacillary form. Tandem electron microscopy revealed
that the long rods were actually chains of 1-2 μm long
bacilli with rounded ends (Figure 5b). S. amnii did not
appear to be motile, the genome does not contain genes
predicted to encode pilin or flagellar proteins, and neither
SEM nor TEM revealed structures that resemble pili or
flagella.
Antibiotic sensitivity
We performed sensitivity assays for a number of antibio-
tics (Table 2). S. amnii displayed high resistance to nafcil-
lin, as is common for other gram-negative organisms.
The standard therapy for BV is metronidazole, but this
therapy is suboptimal, and it is not known whether all
BV-associated organisms are sensitive to this agent.
Interestingly, S. amnii was more sensitive than Gardner-
ella vaginalis, another common BV-associated organism,
to metronidazole. In contrast, S. amnii was more resis-
tant than G. vaginalis to every other drug tested [33].
Gram-negative bacteria are generally resistant to the gly-
copeptide, vancomycin, because the large compound is
unable to pass through the gram-negative outer mem-
brane. In fact, vancomycin sensitivity is often used as an
alternative test to gram staining and more than 99% of
gram-negative clinical bacterial isolates, including Leptro-
trichia species, are vancomycin resistant [34,35]. Thus, it
was surprising that S. amnii was vancomycin-sensitive.
This finding may suggest that the cell envelope of
S. amnii differs from that of typical gram-negative bac-
teria, or it may be related to the large number of per-
meases and transporters predicted to be within the
Figure 5 Electron Micrographs of S. amnii. S. amnii were fixed to either glass cover slips, or copper grids, and visualized by SEM (a) or TEM
(b), respectively.
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S. amnii envelope. Finally, S. amnii exhibited relatively
high levels of resistance to antibiotics such as tetracycline
(> 50 μg/ml) and ciprofloxacin (> 25 μg/ml). The genome
encodes two apparent MATE efflux family homologs.
Members of this family are frequently involved in drug
export and single or multi-drug resistance and could be
involved in resistance to these antimicrobial agents.
Although BV is associated with a greater than 2-fold
increased risk for preterm birth, treatment with metroni-
dazole during pregnancy does not reduce the risk for pre-
term birth [36]. BV involves the formation of a bacterial
biofilm on the vaginal epithelium and the bacteria within
these biofilms appear to be recalcitrant to metronidazole
therapy, leading to a high rate of relapse [37]. Thus, even
though S. amnii was sensitive to metronidazole, it may
exhibit antibiotic tolerance if it occurs within the BV-asso-
ciated biofilm. Therapeutic intervention strategies that tar-
get both the biofilm and the causative species may need to
be developed in order to reduce the rate of BV-associated
preterm birth.
Hemolytic activity and cytotoxicity
Consistent with the observation of alpha hemolysis on
blood agar, S. amnii exhibited weak hemolytic activity.
S. amnii induced the release of ~9% of the hemoglobin
from human red blood cells while an E. coli strain without
hemolytic activity lead to the release of less than 0.5%.
The genome encodes a putative hemolysin of approxi-
mately 28 kDa that could be responsible for the hemolytic
activity. It also encodes a large protein (161 kDa) with
homology to both hemagglutinins and hemolysins. How-
ever, hemagglutination of human red blood cells was not
observed. S. amnii was cytotoxic to ME-180 human cervi-
cal cancer cells. Thus, after 2 hours of exposure, the cervi-
cal epithelial cells exhibited rounding and other cytopathic
changes associated with cytotoxicity (Figure 6a, b),
suggesting the existence of a toxin that causes damage to
these cells. Although a cytotoxin was not annotated in the
genome, one of the hemolysins discussed above could be
responsible for this activity.
Adherence to cervical epithelial cancer cells
S. amnii adhered to ME-180 human cervical cancer cells
(Figure 6c). The image also reveals apparent perforations
in the epithelial cells near the site of bacterial adherence
that were not present in untreated cells (not shown), sug-
gesting that the bacteria may be causing local membrane
damage. The duration of the adherence was minimized
to prevent major cytopathogenic changes; however, it is
likely that cytotoxic effects were starting to manifest. The
S. amnii genome contains only one apparent adhesin
homolog, but three apparent homologs of the Hia family
cell surface protein and a number of YadA domain-con-
taining proteins are present [38,39]. The Hia and YadA
families are autotransporters often implicated in adher-
ence to host tissues and cells. There is also a gene encod-
ing a putative fibronectin-binding protein, which could
play a role in adherence to host tissues.
Other genetic components with potential roles in
virulence
We did not detect any putative quorum-sensing systems.
However, only a few systems including the LuxS system
are highly conserved and it is possible if not likely that a
quorum-sensing system would be difficult to detect. A
putative toxin-antitoxin cassette was found. These cas-
settes can play a role in the stabilization of foreign DNA,
such as plasmids [40]. They have also been shown to
contribute to stress resistance and the persister pheno-
type [41]. Sneathia has been isolated from amniotic fluid
and therefore presumably has the capacity to invade the
uterine cavity and traverse the fetal membranes.
Very little is known about virulence factors that pro-
mote uterine and intra-amniotic invasion although it has
been speculated that enzymes including sialidase that
hydrolyze sialic acid residues or enzymes that degrade
sialylated proteins plays a role in traversal of the cervical
mucus [42]. Sneathia encoded a protein with 63% iden-
tity and 77% similarity to a O-sialoglycoprotein endopep-
tidase that could be involved in the degradation of
sialylated proteins. Evidence suggests that Listeria crosses
the gestational membranes through villous syncytiotro-
phoblasts, and that the invasin, internalin is required for
this process [43]. Sneathia encoded a number of potential
invasins. The YadA-like surface protein mentioned as a
putative adhesin has also been implicated in invasion. It
also encodes a protein with 22% identity and 37% similar-
ity to internalin F from Clostridium perfringens.
Clustered regularly interspaced short palindromic
repeats (CRISPR) are hypervariable sequences that are
Table 2 Sensitivity of S. amnii to antibiotics.
Antibiotic MIC (μg/ml)
Ampicillin 9.8
Nafcillin 1.25
Ciprofloxacin 25
Nalidixic acid 312
Chloramphenicol 1.25
Minocycline 0.97
Tetracycline > 50
Erythromycin > 10
Clindamycin 5
Kanamycin 6
Rifampin 0.4
Metronidazole 0.5
Vancomycin 1.0
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widely distributed in bacteria and archaea and play criti-
cal roles in the adaptation and persistence of a microbial
host in a particular ecosystem by providing acquired
resistance against viruses [44]. Using CRISPFinder [45]
we identified one CRISPR locus with nine 36 bp direct
repeats (DR) located adjacent to the putative cas gene.
These finding suggest the presence of a functional
CRISPR system in S. amnii.
Conclusions
Sneathia is one of the most frequently detected organisms
from amniotic fluid in cases of preterm labor, suggesting
an important role in obstetric health. We detect Sneathia
species in over 40% of mid-vaginal samples in our ongoing
study. The fastidious nature of Sneathia makes cultivation
somewhat difficult, and consequently, very little is known
about its biology or its pathogenic potential. The first
genomic sequence of an organism in the genus Sneathia
provides a starting point for the detailed study of these
organisms and their role in obstetric and gynecologic
health. The genome is small, approximately 1.34 Mbp, and
highly reduced, which may be the basis of its fastidious
nature. Metabolic reconstructions of the genome revealed
capacities that largely reflect the known metabolic, energy,
and anaerobic phenotypes of the bacterium. We did
observe an increased growth phenotype in the presence of
human serum, which was not reproducible using fetal
bovine serum (data not shown), reaffirming the highly spe-
cialized nature of this organism for the human niche. Our
results indicate that S. amnii is able to adhere to, and has
high cytotoxic potential for, cervical epithelial cells. Analy-
sis of the genome sequence revealed a hemolysin, which
could exert this cytotoxic activity. While S. amnii was sen-
sitive to metronidazole in our assay, BV-associated bio-
films may confer antibiotic tolerance to species that
appear sensitive in vitro and have been shown to be
involved in the high rate of relapse. In summary, the gen-
ome of this emerging pathogen reflects its phenotype and
begins to shed light on the reveal its pathogenic potential
and likely role in the gynecologic and obstetric complica-
tions associated with S. amnii.
Description of Sneathia amnii sp.nov
>Sneathia amnii (am’ni.i. Gr. n. amnion, inner membrane
surrounding the fetus; N.L. gen. n. amnii, of the amnion,
pertaining to the amniotic fluid from which the organism
was first isolated) consists of long gram-negative rods as
well as short, amorphous rods and cocci. Closer examina-
tion suggests that the long rods are chains of short rod-
like bacteria. Colonies on blood agar plates after 72 hours
were flat, ~1 mm in diameter, and crystalline. Colonies
on BHI agar containing 10% fresh human blood were ~2
mm in diameter and displayed alpha hemolytic activity.
Cells were catalase-negative, aerotolerant, and optimal
growth occurred under anaerobic conditions. Fermenta-
tion of glycogen, maltose, and glucose were demon-
strated. Lactic acid was produced during fermentative
metabolism. Strains have been isolated from human clini-
cal specimens (mid-vaginal wall, amniotic fluid). The type
strain of S. amnii, Sn35, has a %G+C of ~28% and a gen-
ome of ~1.34 Mbp.
Methods
Subject recruitment
We enrolled adult women from outpatient women’s
health clinics in Virginia as part of the Vaginal Human
Microbiome Project [21]. Incarcerated women and
women who were not scheduled for a vaginal examina-
tion were excluded from the study. Enrollment occurred
between August 2009 and March 2011. Written consent
Figure 6 S. amnii was cytotoxic and adhered to Me180 cells. To assess cytotoxicity, bacteria were added to Me180 monolayers and
monitored by light microscopy during the incubation for phenotypic alterations. In stark contrast to monolayers treated with PBS alone as a
control (a), monolayers exposed to S. amnii rapidly induced cell rounding and loss of adherence (b). To determine whether or not S. amnii
adhered, bacteria were added to Me180 monolayers grown on glass coverslips. Following incubation, the glass coverslips were washed
extensively in PBS, stained, and analyzed by SEM (c).
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was obtained from all study participants and the institu-
tional review boards at Virginia Commonwealth Univer-
sity and the Virginia Department of Health approved the
study. Clinicians obtained swab samples from the mid-
vaginal wall during a speculum examination.
Metagenomic 16S rRNA gene identification of Sneathia in
mid-vaginal samples
DNA was extracted within four hours of collection using
the MoBio PowerSoil DNA processing protocol. The
V1-V3 region of the 16S rRNA gene was PCR-amplified
with bar-coded primers and sequenced on a Roche 454
FLX Titanium Genome Sequencer as described in [21].
Isolation and growth conditions
Bacteria from a swab sample taken from the mid-vaginal
wall of a female volunteer were cultured on chocolate agar
at 37°C for 72 h using the AnaeroPack system (Mitsubishi
Gas Chemical Co, Tokyo, Japan). Single colonies were
isolated and ‘colony’ PCR was performed using 16S
rDNA-specific primers UnivFwd (AGAGTTTGATCCTG
GCTCAG) and UnivRev (5’- GGACTACCAGGGTATC-
TAAT -3’) [46] and PCR Supermix HiFi (Invitrogen).
PCR conditions were 94°C 2 min followed by 35 cycles of
94°C 30 s, 51°C 30 s, and 72°C 30 s. PCR products were
sequenced and species identification was based on identity
with 16S rDNA sequences in the NCBI database. Follow-
ing initial isolation, S. amnii was grown on chocolate agar
or in Brain Heart Infusion (BHI) broth (EMD, Gibbstown,
NJ) supplemented with 1% yeast extract, 2% gelatin, 0.1%
starch, 0.1% glucose, and 5% human serum (sBHI) at 37°C
under anaerobic conditions. To analyze carbohydrate fer-
mentation, 5% human serum, 0.002% phenol red, and 1%
sugar (glucose, starch, maltose, galactose, glycogen, mucin,
mannose, sucrose, or fructose) were added to chemically
defined vaginal fluid medium (described in [47]), 200 μL
of the medium was aliquoted into 96 well plates, and
inoculated with S. amnii. The plates were incubated anae-
robically and inspected visually at 24 h and 48 h for signs
of growth (turbidity) and acid production (change in
media color from red to yellow). Lactic acid was measured
using the Lactate Assay Kit (Biovision, Mountain View,
Ca) according to manufacturer’s instructions.
Superoxide dismutase activity
Approximately 2 × 109 bacteria were resuspended in
500 μL Tris EDTA buffer (TE) and lysed with 500 μL of
1 μm glass beads twice at power 6.5 for 30 s, in a Fastprep
cell disrupter (Thermo). Protein concentration was deter-
mined by measuring A260 nm on a Nanodrop™ spectro-
photmeter. Superoxide Dismutase activity was measured
using the Superoxide Dismutase Assay Kit (Cayman Che-
mical Company, Ann Arbor, MI). Briefly, 10 μL of lysate
were added to 200 μL of the diluted radical detector, the
reaction was initiated by addition of 20 μL diluted
xanthine oxidase and incubated at room temperature for
20 min with gentle mixing. Units of activity were calcu-
lated by comparing the A450 nm to the standard provided
by the manufacturer.
DNA isolation and sequencing
S. amnii was grown in 20 mL sBHI overnight. The cells
were collected by centrifugation, and DNA was isolated
using the Genomic-tip 500/G (Qiagen) according to man-
ufacturer’s instructions. Genome sequencing of S. amnii
was performed with a combined strategy using whole gen-
ome shotgun and 8-kilobase pair (kbp) paired-end reads.
For the shotgun library, fifty nanograms of DNA were
used in a tagmentation reaction with a Nextera™ DNA
Sample Prep Kit (Roche Titanium-compatible, Epicentre
Biotechnologies) following the manufacturer’s protocol.
For the paired end library, genomic DNA was fragmented
into 8-kbp fragments using our HydroShear™ DNA
Shearing Device (GeneMachines, Inc.). Further paired-end
library preparation was performed according to the manu-
facturer’s protocols (Roche). The genomic libraries of
S. amnii were sequenced on the Roche 454 FLX Titanium
system in the Nucleic Acids Research Facilities at VCU. A
total of 583,691 shotgun reads and 287,309 paired-end
reads yielded a ~247-fold coverage of the genome. The
reads were assembled using Newbler™ version 2.0.00.20
software (Roche) using default parameters. The final
assembly generated a single circular scaffold containing
the entire genome. Closure of physical gaps was per-
formed by PCR amplification using primers targeted to
contigs flanking the gaps, followed by fluorescent chain
termination sequence analysis on AB3730 or AB3130
capillary sequencers (Applied Biosystems).
Gene calling and analysis
Genes were called using Glimmer 3 [48] using default
parameters. Transfer RNA genes were predicted using
tRNAscan-SE 1.23 [49] and ribosomal RNA genes were
found by similarity search. Sequences were initially anno-
tated by comparison with currently annotated bacterial
sequences present in NCBI’s NR protein database. Meta-
bolic reconstruction and Gene Ontology classification
assignments were performed using ASGARD software
[50] in conjunction with the UniRef100 database [51].
Other annotation features were predicted as follows: trans-
membrane domains by TMHMM 2.0c [52]; signal pep-
tides by SignalP 3.0b [53]; COG similarities and Pfam
domain composition by rpsblast [24]
Phylogenetic analysis
The 16S rDNA sequences of S. amnii and 31 related
organisms from Fusobacteriaceae family were aligned
using the ClustalW program [54] and the alignments were
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corrected by visual inspection. Phylogenetic analysis was
performed from 1,271 aligned characters of the 16S rRNA
sequences under the maximum likelihood criterion [55].
Maximum likelihood trees were inferred using PhyML 3.0
program [56,57] using the HKY85 model, gamma shape
parameter and proportion of invariable sites. Model para-
meters were estimated in PhyML over the duration of the
tree search. The numbers at the nodes are the result of a
PhyML bootstrap analysis.
Antibiotic sensitivity assay
Antibiotics were serially diluted 2-fold in 200 μL sBHI
in mictotiter wells and 5 μL of a 48 h bacterial culture
was added to each well. The microtiter plates were incu-
bated anaerobically for 48 h and the lowest concentra-
tions of antibiotics that prevented visible bacterial
growth were recorded.
Electron microscopy
For tandem electron microscopy, bacteria grown in sBHI
were collected by centrifugation, washed in sterile deio-
nized water, spotted onto formvar-coated 200-mesh cop-
per grids (Electron Microscopy Sciences, Hatfield, PA),
stained with 2% phosphotungstic acid, and analyzed using
a Jeol JEM-1230 transmission electron microscope
equipped with a Gatan UltraScan 4000SP 4K × 4K CCD
camera. For scanning electron microscopy, washed bac-
teria were fixed in 2% gluteraldehyde. To visualize adher-
ence to cervical epithelial cells, washed bacteria were
added to ME-180 human cervical cancer cell monolayers
grown on poly-lysine-coated glass coverslips, incubated for
5 min, and the monolayers were washed 3 times with 1×
PBS to remove non-adherent bacteria. The monolayers
were fixed in 2% gluteraldehyde. All samples were then
rinsed, fixed in 1% osmium tetraoxide, rinsed, and then
dehydrated with washes of increasing concentrations of
ethanol followed by hexamethadisilizane (HMDS),
mounted, and coated with gold using an EMS 550 Sputter
Coater (Electron Microscopy Sciences, Hatfield, PA) just
prior to viewing. Samples were analyzed using a Zeiss
EVO50XVP Scanning Electron Microscope (Carl Zeiss
SMT, Inc., Peabody, MA).
Hemolysis and hemagglutination
Fresh human blood collected with EDTA as an anticoagu-
lant was centrifuged at 500 × g for 10 min. The serum was
removed, the red blood cells (RBC) were washed once in
10 volumes of phosphate buffered saline (PBS), and resus-
pended in 10 volumes of fresh PBS. 100 μL of the RBC
were added to 0.5 mL microfuge tubes. Approximately 1 ×
106 bacteria from 24 h liquid cultures of S. amnii or E. coli
(negative control) were washed with PBS and added to the
RBC-containing microfuge tubes. PBS was used as a nega-
tive control. The tubes were incubated, stationary, for
30 min at 37°C and observed visually for lattice formation
(hemagglutination). The tubes were centrifuged at 500 × g
for 10 min, the supernatant was collected, and the A450
was determined as a measure of hemoglobin release. RBCs
lysed in pure water were used as a positive control for
100% hemolysis. Bacteria-induced hemolysis was calcu-
lated as the percentage relative to the positive control as
100% [(A450Bacteria - A450PBS)/A450 water].
Cytotoxicity
S. amnii was cultured in sBHI, collected by centrifugation,
and resuspended in PBS to an OD600 = 1.0. Two-fold serial
dilutions were made. ME-180 human cervical cancer cells
were cultured at 37°C in 5% CO2 in McCoy’s 5A medium
(Quality Biologic, Gaithersburg, MD) supplemented with
10% fetal bovine serum and 1 IU mL-1 penicillin/strepto-
mycin (MediaTech, Manassass, VA) in 96 well plates.
Once the cells reached ~90% confluence, the media was
replaced with 100 μL PBS, and 100 μL of each bacterial
dilution was added. The monolayers were monitored every
hour by light microscopy for cytopathogenic changes, such
as cell rounding, loss of adhesion, and disruption of the
monolayer. Photos were taken using an Olympus CK2
light microscope at magnifications of 100× and 400×.
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